scholarly journals Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

2020 ◽  
Vol Volume 11 ◽  
pp. 113-121
Author(s):  
David Lang ◽  
Wolfgang Haslinger ◽  
Kaveh Akbari ◽  
Mario Scala ◽  
Benedikt Hergan ◽  
...  
2020 ◽  
Vol 150 ◽  
pp. 111905 ◽  
Author(s):  
Jinfeng Zhu ◽  
Zhengying Wang ◽  
Shaowei Lin ◽  
Shan Jiang ◽  
Xueying Liu ◽  
...  

2021 ◽  
Vol Volume 14 ◽  
pp. 2553-2560
Author(s):  
Yunqi Bao ◽  
Wei Zhang ◽  
Dandan Shi ◽  
Weili Bai ◽  
Dongdong He ◽  
...  

2016 ◽  
Vol 23 (11) ◽  
pp. 1342-1348 ◽  
Author(s):  
Yanyan Xu ◽  
Hongliang Sun ◽  
Zhenrong Zhang ◽  
Aiping Song ◽  
Wu Wang ◽  
...  

2019 ◽  
Vol 11 (5) ◽  
pp. 1765-1771 ◽  
Author(s):  
Naoya Ishibashi ◽  
Toshiya Maebayashi ◽  
Takuya Aizawa ◽  
Masakuni Sakaguchi ◽  
Masahiro Okada

2019 ◽  
Vol 30 ◽  
pp. iv47
Author(s):  
B. Sato ◽  
M. Kanda ◽  
S. Ito ◽  
H. Teramoto ◽  
Y. Mochizuki ◽  
...  

2002 ◽  
Vol 12 (1) ◽  
pp. 74-79
Author(s):  
C Dimas ◽  
M Frangos-Plemenos ◽  
E Kouskouni ◽  
A Kondis-Pafitis

Abstract.Dimas C, Frangos-Plemenos M, Kouskouni E, Kondis-Pafitis A. Immunohistochemical study of p185 HER2 and DF3 in primary breast cancer and correlation with CA-15-3 serum tumor marker.Human epidermal growth factor receptor 2 (p185 HER2) oncoprotein immunohistochemical expression and DF3 antigen distribution were evaluated in 129 patients with primary breast cancer. p185 HER2 overexpession was positively correlated with the degree of differentiation, metastatic disease, progesterone receptors, and cytoplasmic distribution of DF3 antigen. p185 HER2 overexpression had prognostic significance for the disease-free interval.


Sign in / Sign up

Export Citation Format

Share Document